Page last updated: 2024-08-16

pioglitazone and clopidogrel

pioglitazone has been researched along with clopidogrel in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Angiolillo, DJ; Bass, TA; Box, LC; Desai, B; Ferreiro, JL; Guzman, LA; Rollini, F; Suryadevara, S; Tello-Montoliu, A; Ueno, M; Zenni, M	1
Backman, JT; Itkonen, MK; Neuvonen, M; Neuvonen, PJ; Niemi, M; Tornio, A	1

Reviews

1 review(s) available for pioglitazone and clopidogrel

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for pioglitazone and clopidogrel

Article	Year
Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus. Thrombosis and haemostasis, 2012, Volume: 108, Issue:5 Topics: Aged; Aspirin; Clopidogrel; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Interactions; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Platelet Aggregation; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Thiazolidinediones; Ticlopidine	2012
Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone. Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:8 Topics: Administration, Oral; Adult; Area Under Curve; Biotransformation; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C8 Inhibitors; Drug Administration Schedule; Drug Interactions; Female; Finland; Genotype; Half-Life; Healthy Volunteers; Humans; Hypoglycemic Agents; Male; Metabolic Clearance Rate; Pharmacogenomic Variants; Phenotype; Pioglitazone; Platelet Aggregation Inhibitors; Risk Assessment; Thiazolidinediones; Ticlopidine; Young Adult	2016

Article

Year

Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus.

Thrombosis and haemostasis, 2012, Volume: 108, Issue:5

Topics: Aged; Aspirin; Clopidogrel; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Interactions; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Platelet Aggregation; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Thiazolidinediones; Ticlopidine

2012

Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone.

Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:8

Topics: Administration, Oral; Adult; Area Under Curve; Biotransformation; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C8 Inhibitors; Drug Administration Schedule; Drug Interactions; Female; Finland; Genotype; Half-Life; Healthy Volunteers; Humans; Hypoglycemic Agents; Male; Metabolic Clearance Rate; Pharmacogenomic Variants; Phenotype; Pioglitazone; Platelet Aggregation Inhibitors; Risk Assessment; Thiazolidinediones; Ticlopidine; Young Adult

2016

Other Studies

1 other study(ies) available for pioglitazone and clopidogrel

Article	Year
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Glutathione; Pharmacology; Sulfur Radioisotopes	2011